GlassScriptPhysician profile
David W Peterson
NPI 1942307301
$8,404.75
in general payments reported to CMS, 2019-2025
33 companies · $916 in 2025
The $916 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,477 · 2020: $864 · 2021: $1,213 · 2022: $1,767 · 2023: $1,245 · 2024: $924 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,084.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,379.50 | 2022-2025 | Azure Xt Dr Mri Surescan, Selectsecure, Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $1,007.18 | 2019-2024 | |
| Amgen INC. | $998.95 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $639.31 | 2019-2025 | Coroflow, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $631.91 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $576.13 | 2019-2025 | Jardiance |
| Pfizer INC. | $545.99 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $456.05 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $375.08 | 2019-2025 | Farxiga |
| Preventric Diagnostics, INC. | $278.64 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $224.78 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $210.60 | 2020-2024 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $124.76 | 2021-2023 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $117.98 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $114.86 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $108.38 | 2019-2025 | Watchman Flx |
| Amarin Pharma, INC. | $76.94 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $69.95 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $52.04 | 2019-2023 | Evkeeza |
| W. L. Gore & Associates, INC. | $46.45 | 2019 | |
| Corcept Therapeutics | $46.22 | 2024-2025 | Korlym |
| Acist Medical Systems, INC. | $40.00 | 2022 | |
| Esperion Therapeutics, INC. | $38.51 | 2020-2024 | Nexletol |
| Atricure, INC. | $34.30 | 2023 | |
| Abiomed | $30.89 | 2024 | Impella |
| Kiniksa Pharmaceuticals, LTD. | $30.11 | 2023 | Arcalyst |
| Lilly USA, LLC | $28.43 | 2020-2025 | Zepbound |
| Philips North America LLC | $25.30 | 2024 | (Cm9) Amb Mon & Diag Und |
| Cordis US Corp. | $24.87 | 2025 | Mynx Control |
| Alnylam Pharmaceuticals INC. | $20.88 | 2025 | |
| Scpharmaceuticals INC. | $20.62 | 2024 | |
| Lundbeck LLC | $19.14 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.